Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Zynex stock

Learn how to easily invest in Zynex stock.

Zynex Inc
NASDAQ: ZYXI - USD
$9.30
- $0.21 ( - 2.21%)
MEDICAL DISTRIBUTION

Zynex Inc is a medical distribution business based in the US. Zynex shares (ZYXI) are listed on the NASDAQ and all prices are listed in US Dollars. Zynex employs 774 staff and has a trailing 12-month revenue of around $143 million.

How to buy shares in Zynex

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – ZYXI – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Zynex stock price (NASDAQ: ZYXI)

Use our graph to track the performance of ZYXI stocks over time.

Zynex shares at a glance

Information last updated 2022-10-02.
Latest market close$9.51
52-week range$4.97 - $12.79
50-day moving average $8.98
200-day moving average $7.72
Wall St. target price$16.63
PE ratio 18.5102
Dividend yield $0 (0%)
Earnings per share (TTM) $0.49

Buy Zynex shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 6 of 6
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, ETFs, Cryptocurrency
$0
$0
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
eToro
Stocks, ETFs, Cryptocurrency
$0
$10
8%-12% of your deposit
when you sign up and deposit at least $50. T&Cs apply.
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, TN, and HI.
Tastyworks
Stocks, Options, ETFs, Cryptocurrency
$0
$0
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
Public
Stocks, ETFs, Cryptocurrency
$0
$0
Receive a free stock slice worth between $3–$300
when you sign up for an account and deposit at least $20.
Commission-free trading in stocks and ETFs with a social networking twist.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0
$0
$125 - $625
when you open and fund an account with $25,000 - $250,000+
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
Robinhood
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 3% interest on uninvested cash in your account with Robinhood Gold.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Zynex stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Zynex price performance over time

Historical closes compared with the close of $9.51 from 2022-10-05

1 week (2022-09-29) 1.49%
1 month (2022-09-06) 8.31%
3 months (2022-07-06) 12.68%
6 months (2022-04-04) 54.89%
1 year (2021-10-06) -14.25%
2 years (2020-10-06) -49.87%
3 years (2019-10-04) 12.51
5 years (2017-10-06) 468.54%

Is Zynex stock undervalued or overvalued?

Valuing Zynex stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Zynex's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Zynex's P/E ratio

Zynex's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 19x. In other words, Zynex shares trade at around 19x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

Zynex's EBITDA

Zynex's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $28.6 million.

The EBITDA is a measure of a Zynex's overall financial performance and is widely used to measure a its profitability.

Zynex financials

Revenue TTM $143 million
Operating margin TTM 18.11%
Gross profit TTM $103.4 million
Return on assets TTM 15.93%
Return on equity TTM 31.23%
Profit margin 13.79%
Book value $1.78
Market capitalisation $348.3 million

TTM: trailing 12 months

Zynex share dividends

20%

Dividend payout ratio: 20% of net profits

Recently Zynex has paid out, on average, around 20% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Zynex shareholders could enjoy a 0% return on their shares, in the form of dividend payments. In Zynex's case, that would currently equate to about $0 per share.

While Zynex's payout ratio might seem low, this can signify that Zynex is investing more in its future growth.

Zynex's most recent dividend payout was on 21 January 2022. The latest dividend was paid out to all shareholders who bought their shares by 5 January 2022 (the "ex-dividend date").

Have Zynex's shares ever split?

Zynex's shares were split on a 11:10 basis on 5 January 2022. So if you had owned 10 shares the day before before the split, the next day you'd have owned 11 shares. This wouldn't directly have changed the overall worth of your Zynex shares – just the quantity. However, indirectly, the new 9.1% lower share price could have impacted the market appetite for Zynex shares which in turn could have impacted Zynex's share price.

Zynex share price volatility

Over the last 12 months, Zynex's shares have ranged in value from as little as $4.97 up to $12.7861. A popular way to gauge a stock's volatility is its "beta".

ZYXI.US volatility(beta: 0.81)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Zynex's is 0.8098. This would suggest that Zynex's shares are less volatile than average (for this exchange).

Zynex overview

Zynex, Inc. , through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by field sales representatives; NeuroMove, an electromyography triggered electrical stimulation device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; and E-Wave, an NMES device. It also supplies private labeled products, including electrodes for the delivery of electrical current to the body, and batteries for use in electrotherapy products. In addition, the company distributes Comfortrac/Saunders for cervical traction, JetStream for hot/cold therapy, LSO Back Braces for lumbar support, and knee braces for knee support. Further, it offers Zynex Fluid Monitoring System (CM-1500), a fluid volume monitor, which is a non-invasive medical device for monitoring relative fluid volume changes used in operating and recovery rooms to detect fluid loss during surgery and internal bleeding during recovery; Zynex Wireless Fluid Monitoring System (CM-1600), a noninvasive monitoring device designed to measure relative changes in fluid volume in adult patients; NiCO CO-Oximeter, a laser-based noninvasive co-oximeter; and HemeOx tHb Oximeter, a laser-based total hemoglobin pulse oximeter. The company provides its products for use in pain management and control; stroke and spinal cord injury rehabilitation; hemodynamic monitoring; and pulse oximetry monitoring.

Frequently asked questions

What percentage of Zynex is owned by insiders or institutions?
Currently 43.392% of Zynex shares are held by insiders and 29.937% by institutions.
How many people work for Zynex?
Latest data suggests 774 work at Zynex.
When does the fiscal year end for Zynex?
Zynex's fiscal year ends in December.
Where is Zynex based?
Zynex's address is: 9655 Maroon Circle, Englewood, CO, United States, 80112
What is Zynex's ISIN number?
Zynex's international securities identification number is: US98986M1036
What is Zynex's CUSIP number?
Zynex's Committee on Uniform Securities Identification Procedures number is: 98986M103

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site